Complementary/Alternative IP

Intellectual property strategies in the life sciences sector increasingly encompass forms of protection other than traditional patenting strategies. We assist clients with identifying, protecting, defending, commercialising and exploiting key alternative and supplementary protection of knowledge assets including:

  • orphan indications for medicines and medical devices;
  • certification of Advanced Therapy Medicinal Products (ATMPs);
  • leveraging certifications and industry standards;
  • know-how and confidential information;
  • clinical data;
  • marketing and manufacturing authorisations and similar approvals and permits; and
  • trade mark and design protection in respect of medicines, packaging and medical devices.